Patient Leaflet Updated 13-Jan-2021 | RPH Pharmaceuticals AB
Propylthiouracil Tablets BP 50mg
PROPYLTHIOURACIL TABLETS BP 50 mg
(Propylthiouracil)
1. What Propylthiouracil Tablets are and what they are used for
2. What you need to know before you take Propylthiouracil Tablets
3. How to take Propylthiouracil Tablets
4. Possible side effects
5. How to store Propylthiouracil Tablets
6. Contents of the pack and other information.
The active ingredient in Propylthiouracil Tablets is Propylthiouracil.
Propylthiouracil Tablets are used in the treatment of hyperthyroidism. Hyperthyroidism is where an overactive thyroid gland produces too much thyroid hormone. They are also used to treat Graves’ disease, thyrotoxicosis and thyrotoxic crisis (when levels of thyroid hormone are dangerously high). Propylthiouracil Tablets may also be given to lower very high levels of thyroid hormone before surgery or radioactive iodine treatment. Children may be given Propylthiouracil Tablets to delay the need for surgery (or other treatment to remove part of an overactive thyroid gland).
Talk to your doctor or pharmacist before taking Propylthiouracil Tablets if you:
Some cases of severe liver reactions, including cases with fatal outcome or requiring liver transplant, have been reported in both children and adults treated with propylthiouracil. You should inform your doctor immediately if you develop symptoms of liver disease, such as nausea, feeling sick, diarrhoea, yellow discolouration of the skin or eyes, dark urine, pale stools, bleeding easily, itching or chills.
Some medicines can interfere with your treatment. Tell your doctor if you are taking any of the following:
The potential of Propylthiouracil Tablets to cause harm to an unborn baby is uncertain.
If you are pregnant, think you may be pregnant or are planning to have a baby, tell your doctor straight away.
You may need treatment with Propylthiouracil Tablets during pregnancy if the potential benefit outweighs the potential risk to you and your unborn baby.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
If you see another doctor or visit a hospital, remember to tell them what medicines you are already taking.
You must take your tablets exactly as your doctor has told you to. The dose will be on the pharmacist’s label. Check the label carefully. It should tell you how many tablets to take and how often. If you are not sure, ask your doctor or pharmacist. Your doctor may want you to have regular blood tests or other tests to check your condition and to make sure that you are taking the right dose.
Swallow the tablets whole with water.
ADULTS:
For management of hyperthyroidism and prior to surgery: the starting dose is between 300mg and 600mg a day (6 to 12 tablets), taken as a single dose or in divided doses. This may be gradually reduced to between 50mg and 150mg (1 to 3 tablets) daily as your condition improves.
In preparation for radioactive iodine therapy: The dose is as above and should be taken for several weeks prior to radioactive iodine therapy. Treatment should be stopped 2 to 4 days before iodine treatment.
For thyrotoxic crisis: The dose is 200mg (4 tablets) every 4 to 6 hours for the first 24 hours. This is then reduced as the condition improves. Elderly patients will be given the adult dose mentioned above. Patients with liver or kidney problems may be given a lower dose.
CHILDREN:
Aged 6 to 10 years: The starting dose is 50mg to 150mg a day (1 to 3 tablets).
Aged over 10 years: The starting dose is 150mg to 300mg a day (3 to 6 tablets).
Neonates (babies less than 4 weeks old): The dose will be worked out depending on the baby’s weight. The usual daily dose is 5mg to 10mg for each kilogram of body weight.
If you forget to take a dose at the right time, take it as soon as you remember. Do not take two doses together. If it is almost time to take the next dose, wait until then and then carry on as before.
What to do if you take too many tablets: It is important not to take too many tablets. Contact your nearest hospital casualty department or a doctor for advice if you have swallowed too many tablets or if you think a child has swallowed any. Take this leaflet, and any tablets that you still have to show the doctor.
Like all medicines, Propylthiouracil Tablets can cause side effects, although not everybody gets them.
Frequency unknown: Liver failure, liver inflammation.
Other rare side effects are:
If you feel unwell in any other way, tell your doctor as soon as you can.
Your body may make less white blood cells than normal which may make you more prone to picking up infections. Levels will go back to normal when you stop taking your treatment.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme on the MHRA website www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Store the tablets in their original pack away from direct light. Store below 25°C.
Keep all medicines out of the sight and reach of children.
Do not take the tablets after the expiry date which is printed on the carton and label.
You should take any tablets that are out of date or which you no longer need back to your pharmacist.
There is one strength of Propylthiouracil Tablets, 50 milligrams (mg).
Propylthiouracil Tablets contain the active ingredient Propylthiouracil. Each tablet contains Propylthiouracil BP 50 milligrams (mg) (active ingredient); and alginic acid, maize starch, lactose, magnesium stearate and povidone 30 (other ingredients).
Propylthiouracil Tablets are white and come in packs of 56 or 100 tablets.
Marketing Authorisation Holder:
Manufacturer:
This leaflet was last revised in December 2020
SIN 4664P
MAL 19940154A
PET004675-UK
Box 603, 101 32 Stockholm, Sweden
+44 (0)845 023 0467
+44(0)845 023 0467
www.recipharm.com
+44 207 862 1716
+44(0)845 023 0467